Unlike traditional NSAIDs, IGU does not cause gastrointestinal ulcer-like side effects in fasting rats and can inhibit kininogen in kaolin-induced inflammatory responses (Peng et al., 2024). This evidence concerns the gene KNG1 and ulcer disease.